A Study of WX390 Combined With Toripalimab in Patients With Advanced Gastric-type Endocervical Adenocarcinoma With STK11 Mutations
Clinical trial NCT06124963 · RECRUITING
Trial details
- NCT number
- NCT06124963
- Sponsor
- Shanghai Jiatan Pharmatech Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-25
- Primary completion
- 2025-12-12
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.